Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis

Bone Marrow Transplant. 2022 Jun;57(6):1007-1009. doi: 10.1038/s41409-022-01659-w. Epub 2022 Apr 2.

Authors

Joselle Cook^#¹, Wilson I Gonsalves^#², Morie A Gertz², Alissa Visram^{2

3}, Rahma Warsame², Martha Q Lacy², Angela Dispenzieri², David Dingli², Prashant Kapoor², Taxiarchis V Kourelis², Suzanne R Hayman², Robert A Kyle², Eli Muchtar², Shaji K Kumar², William J Hogan², Eapen K Jacob⁴, Francis K Buadi²

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA. [email protected].
² Division of Hematology, Mayo Clinic, Rochester, MN, USA.
³ University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
⁴ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

^# Contributed equally.

PMID: 35368041
DOI: 10.1038/s41409-022-01659-w

No abstract available

Publication types

Letter

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Immunoglobulin Light-chain Amyloidosis* / therapy
Multiple Myeloma* / complications
Multiple Myeloma* / therapy
Transplantation, Autologous